Document Detail


Murine hypersensitivity pneumonitis: interleukin-4 administration partially abrogates the disease process.
MedLine Citation:
PMID:  1501575     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
C57BL-6 inbred mice were given intranasal instillations of Faeni rectivirgula (150 micrograms/day, 3 days a week for 3 weeks) to produce a lung inflammatory reaction which mimics Farmers' lung in humans. Challenged mice developed a strong inflammatory response in their lungs, based on various markers (lung index, bronchoalveolar cell number, fibrosis). The effect of interleukin-4 (IL-4) was studied by infusing mice intraperitoneally with 100, 1000 or 10,000 units of IL-4 weekly during the challenge period. It was shown that IL-4 infusion decreased the inflammatory response, as seen by a decreased lung index (1.7 in mice given F. rectivirgula and 10(3) U IL-4 and 1.31 in mice given antigen and 10(4) U IL-4 weekly versus 2.3 in mice instilled with F. rectivirgula). Interleukin-4 infusion also partially abrogated the F. rectivirgula-induced alveolitis, as seen by a decrease in cell numbers in the broncho-alveolar lavage (BAL) (1.3 x 10(5) cells in saline-instilled mice; 8.3 x 10(5) cells in mice given 10(3) U IL-4 and F. rectivirgula; 3.2 x 10(5) cells in mice given antigen and 10(4) U IL-4; 1.8 x 10(6) cells in mice given F. rectivirgula only). Also, it was apparent that IL-4 administration could partially block the appearance of the fibrosis induced by F. rectivirgula (220 micrograms of hydroxyproline/lung in challenged mice; 170 micrograms/lung in challenged mice given 10(3) U IL-4; 131 micrograms/lung in mice given antigen and 10(4) U IL-4 and c. 100 micrograms/lung in control animals). Infusion of 10(2) U IL-4 weekly had no statistical effect on any marker of inflammation.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
E Ghadirian; M Denis
Related Documents :
1501575 - Murine hypersensitivity pneumonitis: interleukin-4 administration partially abrogates t...
8083605 - Molecular mechanisms of il-4 effect on hiv expression in promonocytic cell lines and pr...
9759945 - Effect of sucralfate on gastric mucosal inflammatory responses induced by helicobacter ...
24169045 - Effect of peripherally administered leptin antagonist on whole-body metabolism, and bon...
21418375 - A new method for in vivo visualization of vessel remodeling using a near-infrared dye.
1765695 - Topical niclosamide as a protective agent against schistosome infection.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Microbial pathogenesis     Volume:  12     ISSN:  0882-4010     ISO Abbreviation:  Microb. Pathog.     Publication Date:  1992 May 
Date Detail:
Created Date:  1992-09-16     Completed Date:  1992-09-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8606191     Medline TA:  Microb Pathog     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  377-82     Citation Subset:  IM    
Affiliation:
Montreal General Hospital Research Institute, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alveolitis, Extrinsic Allergic / drug therapy*,  immunology
Animals
Bronchoalveolar Lavage Fluid / cytology
Disease Models, Animal
Interleukin-4 / therapeutic use*
Macrophages, Alveolar / immunology
Mice
Mice, Inbred C57BL
Tumor Necrosis Factor-alpha / metabolism
Chemical
Reg. No./Substance:
0/Tumor Necrosis Factor-alpha; 207137-56-2/Interleukin-4

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Receptor utilization by reovirus type 3: distinct binding sites on thymoma and fibroblast cell lines...
Next Document:  Expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli using a two cistron...